StockTipsArenaBeta

BUY Aurobindo Pharma — ICICI Securities

BUYAurobindo Pharma
Aurobindo Pharma share price target & all analyst calls

byICICI SecuritiesHorizon: NA (inferred 1 year)15 Feb 2026via Institutional / Brokerage Research

Entry₹1,145.6Inferred
Target₹1,425
Total upside +24.39% (call closed)
Stop lossNot given
Exit₹1,42522 Apr 2026, 12:04 pm
Target hit+24.39%0.00%upside left
Follow ICICI Securities for new calls(67% target hit, 1026 closed calls)Get alertsWatch AUROPHARMA for new buy/sell callsGet alertsSee 11 active Long-term calls on AUROPHARMASee 211 active Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 22 Oct, 5:33 pm IST
2 supporting1 neutral0 opposing
Supports the BUY call (2)

2 advisors have active short-term BUY calls on this stock

Advisor consensus · adjacent horizon·6 Apr · 2w ago

3 other SEBI-registered advisors have active long-term BUY calls on this stock

Advisor consensus · same horizon·1 Apr · 3w ago

Neutral / worth noting (1)

Aurobindo Pharma Ltd submitted a Letter of Offer for the buyback of 5,423,728 fully paid-up equity shares.

BSE · Company Update·21 Apr · today

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Aurobindo Pharma

All analyst calls on Aurobindo Pharma

More from ICICI Securities

Every call and its outcome